Skip to content

EQ

Equillium, Inc.

NASDAQ · USHealthcareBiotechnology
$2.47-4.63%

Price as of Jul 20, 2026

EQ capital

Equillium, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.01x
Net debt / equity
-1.02x
Debt / assets
0.01x
Debt / EBITDA
-0.04x
Net debt / EBITDA
3.20x

Liquidity & coverage

Current ratio
18.62x
Quick ratio
18.62x
Cash ratio
18.33x
Interest coverage
EBITDA / interest
Working capital
$58.9M

Cash & dividend

FCF / debt
-27.35x
Cash flow / debt
-27.28x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.